Biodegradable MIP Nanoparticles for Specific Biomarker Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic tests for detecting biomarkers, such as proteins associated with diseases, lack specificity and sensitivity, are invasive, expensive, and have poor shelf life, and alternative methods using antibodies and contrast agents are limited by toxicity concerns.
Innovation Solution
Development of molecularly imprinted polymer nanoparticles (MIPNPs) with a biodegradable inner core and an outer shell specific for target molecules, optimized for high affinity and selectivity, and synthesized using poly(maleic anhydride-alt-1-octadecene)-g-poly(ethylene glycol) methacrylate (PMAO-g-PEGMA), allowing for non-invasive in vivo diagnostics and easy scalability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If antibodies and enzymes are used for diagnostic tests, then recognition specificity is improved, but cost increases and shelf life deteriorates
Solution Approach 1:
The patent creates molecular imprints that are copies of the target molecule's binding interface. These imprints replicate the recognition capability of natural antibodies without using the expensive biological materials themselves. The imprinted cavities in the polymer matrix serve as artificial copies of antibody binding sites, achieving similar specificity at lower cost.
Solution Approach 2:
The patent changes the material parameters from biological proteins (antibodies/enzymes) to synthetic polymers. This parameter change includes transitioning from organic macromolecules with complex tertiary structures to crosslinked polymer networks with imprinted cavities, thereby improving stability and shelf life while reducing cost.
2Measurement precision
If antibodies and contrast agents are used for in vivo optical imaging, then diagnostic capability is improved, but toxicity increases
Solution Approach 1:
The patent employs biodegradable polymer materials that can safely degrade in the body after serving their diagnostic function. These materials are designed to be non-toxic and environmentally friendly, replacing persistent foreign substances with biocompatible, short-lived polymers that the body can naturally metabolize and eliminate.
Solution Approach 2:
The patent creates composite nanoparticle systems combining biodegradable polymer matrices with molecular imprints. These composite structures integrate the recognition capability of MIPs with the biocompatibility of degradable polymers, achieving both diagnostic functionality and reduced toxicity through material composition design.
3Productivity
If molecularly imprinted polymers are used, then cost is reduced and scalability is improved, but biodegradability and biocompatibility worsen
Solution Approach 1:
The patent changes the polymer material parameters from conventional non-degradable polymers (like polystyrene or polyacrylonitrile) to biodegradable polymers (such as poly(lactic-co-glycolic acid) or polycaprolactone). This parameter change maintains the molecular imprinting capability while adding biocompatibility and biodegradability properties essential for in vivo applications.
Solution Approach 2:
The patent develops composite materials combining biodegradable polymer bases with functional monomers for molecular imprinting. These composite structures preserve the recognition specificity of MIPs while the biodegradable matrix ensures safety for biological applications, resolving the contradiction between functionality and biocompatibility.
4Device complexity
If conventional diagnostic tests are used, then simplicity is maintained, but sensitivity and specificity deteriorate
Solution Approach 1:
The patent applies local quality by creating highly specific binding sites within a simple polymer matrix. The molecular imprints provide localized recognition functionality at specific cavities within the material, concentrating the diagnostic capability in precise locations while maintaining overall system simplicity. This allows high sensitivity without complex device architecture.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
MIPNPs demonstrate enhanced specificity and binding capacity for target molecules, avoiding immunologic responses and toxicity, and can be used for accurate detection of biomarker variations, offering a cost-effective and non-invasive diagnostic solution.
Implementation Method 1
stabilized by an amphiphilic polymer... hydrophobic biodegradable nanoparticles... poly(maleic anhydride-alt-1-octadecene)-g-poly(ethylene glycol) methacrylate
Implementation Method 2
stabilized by an amphiphilic polymer... outer shell having at least one binding cavity specific for a target molecule
Implementation Method 3
Molecularly imprinted polymers (MIPs) are polymers that can selectively recognize target molecules. This is achieved by allowing the target molecule, referred to as the template, to pre-assemble with certain monomers that have functional groups that can form non-covalent interactions with functional groups in the structure of the template
Implementation Method 4
functional monomers with positively charged functional groups can form electrostatic interactions with negatively charged side chains of amino acid residues on the surface of a protein
Implementation Method 5
a polymer network with cavities that are complementary to the template in both shape and functionality is formed
Implementation Method 6
After pre-assembly, free radical polymerization is initiated and a polymer network with cavities that are complementary to the template in both shape and functionality is formed
Implementation Method 7
biodegradable inner core... poly(maleic anhydride-alt-1-octadecene)-g-poly(ethylene glycol) methacrylate... biodegradable nanoparticles
Implementation Method 8
biodegradable nanoparticles... body can easily break it down into non-toxic components
Data Source
AI summary
The present disclosure relates to a novel type of recognitive biodegradable nanoparticles and their preparations. In particular, the present disclosure relates to combinations of MIPs and biodegradable nanoparticles.